Publications in collaboration with researchers from University of Texas MD Anderson Cancer Center (2)

2018

  1. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Núm. 16, pp. E3769-E3778

2014

  1. Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and hedgehog signaling activation

    Cancer Research, Vol. 74, Núm. 13, pp. 3512-3524